CSCJC-3456

N/A

Report date: 2025/02/24 15:11:18
NME

Base Information

Drug NameCSCJC-3456
Drug Alias NameCSCJC3456CSCJC-3456
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonistsStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor RET inhibitors +[4] 
TargetsFibroblast growth factor receptorsStem cell growth factor receptorTyrosine-protein kinase receptor RET +[4] 
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co LtdHebei Changshan Biochemical Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHebei Changshan Biochemical Pharmaceutical Co LtdChangshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A